Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Treatment of IMM cells with Oscillibater valericigenes

ABSTRACT: Treatment of IMM cells with Oscillibater valericigenes

PROVIDER: PRJNA840937 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR19340637.fastq.gz	Fastqsanger.gz
	SRR19340638.fastq.gz	Fastqsanger.gz
	SRR19340639.fastq.gz	Fastqsanger.gz
	SRR19340640.fastq.gz	Fastqsanger.gz
	SRR19340641.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 12

Similar Datasets

Treatment of IMM cells with Oscillibater valericigenes

Project description:Microbiota contributes to induction of type 2 diabetes by high-fat/high-sugar (HFHS), but which organs/pathways are impacted by microbiota remains unknown. Using multi-organ network and transkingdom analyses, we found that microbiota-dependent. impairment of OXPHOS /mitochondria in white adipose tissue (WAT) plays a primary role in regulating systemic glucose metabolism. The follow-up analysis established that Mmp12+ macrophages link microbiota-dependent inflammation and OXPHOS damage in WAT. Moreover, the molecular signature of Mmp12+ macrophages in WAT was associated with insulin resistance in obese patients. Next, we tested functional effects of MMP12 and found that Mmp12 genetic deficiency or MMP12 inhibition improved glucose metabolism in conventional, but not in germfree mice. MMP12 treatment induced insulin resistance in adipocytes. TLR2-ligands present in Oscillibacter valericigenes bacteria, which are expanded by HFHS, induce Mmp12 in WAT macrophages in a MYD88-ATF3-dependent manner. Thus, HFHS induces Mmp12+ macrophages and MMP12, representing a microbiota-dependent bridge between inflammation and mitochondrial damage in WAT and causing insulin resistance. doi: https://doi.org/10.1084/jem.20220017

2022-05-27 | GSE203488 | GEO

Treatment of RAW 264.7 cells with Oscillibater valericigenes

Project description:Treatment of RAW 264.7 cells with Oscillibater valericigenes

| PRJNA841183 | ENA

Oscillibacter valericigenes

Project description:Oscillibacter valericigenes overview

| PRJNA42897 | ENA

Treatment of RAW 264.7 cells with Oscillibater valericigenes

2022-05-24 | GSE203516 | GEO

Oscillibacter valericigenes Sjm18-20

Project description:Oscillibacter valericigenes Sjm18-20 Genome sequencing

| PRJNA41823 | ENA

IMM Beer Sequencing

Project description:Sequence data from the strains used to make IMM Raspberry sour beer

| PRJEB78950 | ENA

Teseptimavirus T7 isolate:IMM-002

Project description:Teseptimavirus T7 isolate:IMM-002 Genome sequencing and assembly

| PRJNA396434 | ENA

Epididymal adipose tissue gene sequencing of mice on a normal diet, with or without gavage of Oscillibacter valericigenes

Project description:Paper abstract: Microbiota contribute to the induction of type 2 diabetes by high-fat/high-sugar (HFHS) diet, but which organs/pathways are impacted by microbiota remain unknown. Using multiorgan network and transkingdom analyses, we found that microbiotadependent impairment of OXPHOS/mitochondria in white adipose tissue (WAT) plays a primary role in regulating systemic glucose metabolism. The follow-up analysis established that Mmp12+ macrophages link microbiota-dependent inflammation and OXPHOS damage in WAT. Moreover, the molecular signature of Mmp12+ macrophages in WAT was associated with insulin resistance in obese patients. Next, we tested the functional effects of MMP12 and found that Mmp12 genetic deficiency or MMP12 inhibition improved glucose metabolism in conventional, but not in germ-free mice. MMP12 treatment induced insulin resistance in adipocytes. TLR2-ligands present in Oscillibacter valericigenes bacteria, which are expanded by HFHS, induce Mmp12 in WAT macrophages in a MYD88-ATF3–dependent manner. Thus, HFHS induces Mmp12+ macrophages and MMP12, representing a microbiota-dependent bridge between inflammation and mitochondrial damage in WAT and causing insulin resistance.

2022-10-13 | GSE215226 | GEO

A Study of IMM-101 in Combination With Radiation Induced Tumour Necrosis in Colorectal Cancer

Project description:The purpose of this study is to investigate the safety and effects of IMM 101 in combination with a single targeted dose of radiation in patients with metastatic colorectal cancer in whom chemotherapy or other treatment has not been effective. Administration of radiation (using the CyberKnife) to the target tumour growth in the liver results in the release of tumour material. IMM-101 may help the immune system to react to the tumour material released from the damaged tumour, and so have a beneficial effect in slowing down the rate of growth of other tumour growths in the liver and other organs.

| 2120872 | ecrin-mdr-crc

Study of IMM 101 in Combination With Standard of Care in Patients With Metastatic or Unresectable Cancer

Project description:During this open label study patients will receive IMM-101 in conjunction with a recognised standard of care for metastatic or unresectable cancer for the patient’s specific tumour type. The primary objective of the study is to provide safety data for IMM-101 in combination with a number of selected standard of care regimens.

| 2233312 | ecrin-mdr-crc

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data